Katia Alves Selected Research

Reverse Transcriptase Inhibitors

11/2022

Safety and efficacy of vebicorvir administered with entecavir in treatment-naïve patients with chronic hepatitis B virus infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Katia Alves Research Topics

Disease

12	Infections 11/2022 - 11/2013
5	Fibrosis (Cirrhosis) 11/2022 - 01/2018
3	Chronic Hepatitis C 11/2015 - 11/2013
2	COVID-19 01/2023 - 01/2023
2	Chronic Hepatitis B 01/2023 - 11/2022
2	Anemia 01/2017 - 11/2013
1	Asymptomatic Diseases 01/2023
1	Viremia 01/2022
1	Nasopharyngitis 01/2017
1	Virus Diseases (Viral Diseases) 11/2015
1	Disease Progression 01/2015
1	Hepatitis C 10/2011

Drug/Important Bio-Agent (IBA)

6	ombitasvirIBA 02/2019 - 11/2015
6	paritaprevirIBA 02/2019 - 11/2015
5	Ribavirin (Virazole)FDA LinkGeneric 02/2019 - 11/2013
5	Ritonavir (Norvir)FDA Link 02/2019 - 11/2015
4	glecaprevir and pibrentasvirIBA 04/2018 - 01/2018
3	Antiviral Agents (Antivirals)IBA 02/2019 - 11/2015
3	P-300IBA 04/2018 - 01/2018
2	Recombinant ProteinsIBA 01/2023 - 01/2023
2	VaccinesIBA 01/2023 - 01/2023
2	NVX-CoV2373 adjuvated lipid nanoparticleIBA 01/2023 - 01/2023
2	DNA (Deoxyribonucleic Acid)IBA 11/2022 - 01/2022
2	dasabuvirIBA 02/2019 - 10/2018
2	InterferonsIBA 10/2018 - 01/2018
2	N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA 01/2015 - 11/2013
1	Immunoglobulin G (IgG)IBA 01/2023
1	Nucleocapsid ProteinsIBA 01/2023
1	entecavir FDA Link 11/2022
1	Reverse Transcriptase InhibitorsIBA 11/2022
1	Hepatitis B e AntigensIBA 11/2022
1	glecaprevirIBA 01/2018
1	pibrentasvirIBA 01/2018
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	BilirubinIBA 01/2017
1	lomibuvirIBA 07/2014
1	NucleosidesIBA 07/2014
1	telaprevirIBA 07/2014
1	Erythropoietin FDA Link 11/2013
1	Atorvastatin (Lipitor)FDA Link 10/2011
1	Amlodipine (Norvasc)FDA LinkGeneric 10/2011
1	Cytochrome P-450 CYP3AIBA 10/2011

Therapy/Procedure

3	Therapeutics 01/2023 - 11/2013
1	Aftercare (After-Treatment) 01/2015
1	Drug Tapering 11/2013